I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Faderl, Stefan
189
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
P516: CARDIOTOXICITY OF CPX-351 VS 7 + 3 IN PATIENTS WITH U..:
Mitchell, Joshua D
;
Pfeiffer, Michael
;
Boehmer, John
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429217/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
2
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by..:
Cortes, Jorge E
;
Lin, Tara L
;
Asubonteng, Kobby
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598030/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
3
Frequency of infusion-related reactions with CPX-351 treatm..:
Jacoby, Meagan A
;
Finn, Laura
;
Emadi, Ashkan
...
Leukemia & Lymphoma. , 2021
Link:
http://hdl.handle.net/10..
?
4
Quality-adjusted Time Without Symptoms of disease or Toxici..:
Cortes, Jorge E
;
Lin, Tara L
;
Uy, Geoffrey L
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276472/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
5
Phase 1 study of CWP232291 in patients with relapsed or ref..:
Lee, Je-Hwan
;
Faderl, Stefan
;
Pagel, John M
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218422/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
6
A phase 1 trial of vadastuximab talirine combined with hypo..:
Fathi, Amir T
;
Erba, Harry P
;
Lancet, Jeffrey E
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265631/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
7
Long-term outcome of acute promyelocytic leukemia treated w..:
Abaza, Yasmin
;
Kantarjian, Hagop
;
Garcia-Manero, Guillermo
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413297/. , 2017
Link:
http://www.ncbi.nlm.nih...
?
8
Safety, efficacy, and clinical utility of asparaginase in t..:
Koprivnikar, Jamie
;
McCloskey, James
;
Faderl, Stefan
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348069/. , 2017
Link:
http://www.ncbi.nlm.nih...
?
9
Ofatumumab and lenalidomide for patients with relapsed or r..:
Vitale, Candida
;
Falchi, Lorenzo
;
Ten Hacken, Elisa
...
info:eu-repo/semantics/altIdentifier/pmid/26733610. , 2016
Link:
http://hdl.handle.net/23..
?
10
Prognostic impact of persistent cytogenetic abnormalities a..:
Short, Nicholas J
;
Kantarjian, Hagop M
;
Jabbour, Elias J
...
qt9w98n6bv. , 2016
Link:
https://escholarship.org..
?
11
Prognostic impact of persistent cytogenetic abnormalities a..:
Short, Nicholas J
;
Kantarjian, Hagop M
;
Jabbour, Elias J
...
qt5n6346w2. , 2016
Link:
https://escholarship.org..
?
12
The role of combined fludarabine, cyclophosphamide and ritu..:
Skarbnik, Alan P
;
Faderl, Stefan
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305006/. , 2016
Link:
http://www.ncbi.nlm.nih...
?
13
Long-term durable remission by cladribine followed by ritux..:
Chihara, Dai
;
Kantarjian, Hagop
;
O'Brien, Susan
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396841/. , 2016
Link:
http://www.ncbi.nlm.nih...
?
14
Long‐term durable remission by cladribine followed by ritux..:
Chihara, Dai
;
Kantarjian, Hagop
;
O'Brien, Susan
...
qt1mc6v0kq. , 2016
Link:
https://escholarship.org..
?
15
A Phase I Study of Evofosfamide, an Investigational Hypoxia..:
Badar, Talha
;
Handisides, Damian R
;
Benito, Juliana M
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946992/. , 2016
Link:
http://www.ncbi.nlm.nih...
1-15